Evaluation of adjuvant estramustine phosphate, cyclophosphamide, and observation only for node-positive patients following radical prostatectomy and definitive irradiation. Investigators of the National Prostate Cancer Project.

MLA

Schmidt, J. D., et al. “Evaluation of Adjuvant Estramustine Phosphate, Cyclophosphamide, and Observation Only for Node-Positive Patients Following Radical Prostatectomy and Definitive Irradiation. Investigators of the National Prostate Cancer Project.” The Prostate, vol. 28, no. 1, Jan. 1996, pp. 51–57. EBSCOhost, https://doi.org/10.1002/(SICI)1097-0045(199601)28:1<51::AID-PROS7>3.0.CO;2-R.

APA

Schmidt, J. D., Gibbons, R. P., Murphy, G. P., & Bartolucci, A. (1996). Evaluation of adjuvant estramustine phosphate, cyclophosphamide, and observation only for node-positive patients following radical prostatectomy and definitive irradiation. Investigators of the National Prostate Cancer Project. The Prostate, 28(1), 51–57. https://doi.org/10.1002/(SICI)1097-0045(199601)28:1<51::AID-PROS7>3.0.CO;2-R

Chicago

Schmidt, J D, R P Gibbons, G P Murphy, and A Bartolucci. 1996. “Evaluation of Adjuvant Estramustine Phosphate, Cyclophosphamide, and Observation Only for Node-Positive Patients Following Radical Prostatectomy and Definitive Irradiation. Investigators of the National Prostate Cancer Project.” The Prostate 28 (1): 51–57. doi:10.1002/(SICI)1097-0045(199601)28:1<51::AID-PROS7>3.0.CO;2-R.